date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.368365875038052.
The log-likelihood improved by 2.905.
Iteration 2 of at most 500:
Optimizing with step length 0.7248966134975.
The log-likelihood improved by 2.386.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 1.683.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1784.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       3       25     1324     1085      791      365      338      348 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     271      194      112       66       51       15        9        1 
degree16 degree17 
       1        1 
1 
disease_progression 
H-positive risk:  845 930 110 882 463 125 843 449 118 66 116 53 
H-negative risk:  930 845 843 882 449 463 125 110 116 118 53 66 
New BC onsets:  0
BC status:  5000 
BC subtype:  5000 

clinical_engagement 
diagnosis 
demography 
61 new agents 
2 
disease_progression 
H-positive risk:  848 930 114 890 458 127 837 444 119 64 116 53 
H-negative risk:  930 848 837 890 444 458 127 114 116 119 53 64 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 1 1 

clinical_engagement 
diagnosis 
demography 
56 new agents 
3 
disease_progression 
H-positive risk:  851 929 114 891 448 128 840 447 118 63 117 54 
H-negative risk:  929 851 840 891 447 448 128 114 117 118 54 63 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
61 new agents 
4 
disease_progression 
H-positive risk:  857 938 115 891 446 130 827 447 117 63 115 54 
H-negative risk:  938 857 827 891 447 446 130 115 115 117 54 63 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 6 1 

clinical_engagement 
diagnosis 
demography 
51 new agents 
5 
disease_progression 
H-positive risk:  858 949 115 889 444 131 824 441 118 63 113 55 
H-negative risk:  949 858 824 889 441 444 131 115 113 118 55 63 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 9 1 

clinical_engagement 
diagnosis 
demography 
62 new agents 
6 
disease_progression 
H-positive risk:  862 958 117 892 436 131 823 437 118 63 110 53 
H-negative risk:  958 862 823 892 437 436 131 117 110 118 53 63 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 10 2 

clinical_engagement 
diagnosis 
demography 
57 new agents 
7 
disease_progression 
H-positive risk:  866 957 118 886 431 132 828 436 115 64 112 55 
H-negative risk:  957 866 828 886 436 431 132 118 112 115 55 64 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 11 2 

clinical_engagement 
diagnosis 
demography 
50 new agents 
8 
disease_progression 
H-positive risk:  871 963 118 885 424 131 830 433 117 63 112 53 
H-negative risk:  963 871 830 885 433 424 131 118 112 117 53 63 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 13 2 

clinical_engagement 
diagnosis 
demography 
66 new agents 
9 
disease_progression 
H-positive risk:  868 977 117 884 420 133 836 422 115 63 114 51 
H-negative risk:  977 868 836 884 422 420 133 117 114 115 51 63 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 15 2 

clinical_engagement 
diagnosis 
demography 
53 new agents 
10 
disease_progression 
H-positive risk:  867 985 118 889 414 134 838 416 113 62 113 51 
H-negative risk:  985 867 838 889 416 414 134 118 113 113 51 62 
New BC onsets:  16
BC status:  4984 16 
BC subtype:  4984 14 2 

clinical_engagement 
diagnosis 
demography 
60 new agents 
11 
disease_progression 
H-positive risk:  868 997 120 883 408 135 837 412 114 64 111 51 
H-negative risk:  997 868 837 883 412 408 135 120 111 114 51 64 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 15 4 

clinical_engagement 
diagnosis 
demography 
60 new agents 
12 
disease_progression 
H-positive risk:  876 999 121 885 401 136 829 409 116 65 111 52 
H-negative risk:  999 876 829 885 409 401 136 121 111 116 52 65 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 17 4 

clinical_engagement 
diagnosis 
demography 
65 new agents 
13 
disease_progression 
H-positive risk:  797 921 106 965 398 123 914 403 129 65 125 54 
H-negative risk:  921 797 914 965 403 398 123 106 125 129 54 65 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 20 4 

clinical_engagement 
diagnosis 
demography 
225 new agents 
14 
disease_progression 
H-positive risk:  850 959 107 912 417 129 847 414 119 72 117 57 
H-negative risk:  959 850 847 912 414 417 129 107 117 119 57 72 
New BC onsets:  29
BC status:  4971 29 
BC subtype:  4971 20 9 

clinical_engagement 
diagnosis 
demography 
61 new agents 
15 
disease_progression 
H-positive risk:  851 965 110 914 413 128 840 411 119 71 120 58 
H-negative risk:  965 851 840 914 411 413 128 110 120 119 58 71 
New BC onsets:  30
BC status:  4970 30 
BC subtype:  4970 21 9 

clinical_engagement 
diagnosis 
demography 
58 new agents 
16 
disease_progression 
H-positive risk:  851 967 109 918 411 131 840 406 120 70 120 57 
H-negative risk:  967 851 840 918 406 411 131 109 120 120 57 70 
New BC onsets:  31
BC status:  4969 31 
BC subtype:  4969 22 9 

clinical_engagement 
diagnosis 
demography 
54 new agents 
17 
disease_progression 
H-positive risk:  861 960 113 919 407 130 840 401 119 70 122 58 
H-negative risk:  960 861 840 919 401 407 130 113 122 119 58 70 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 24 10 

clinical_engagement 
diagnosis 
demography 
66 new agents 
18 
disease_progression 
H-positive risk:  865 971 112 921 406 129 834 392 120 68 123 59 
H-negative risk:  971 865 834 921 392 406 129 112 123 120 59 68 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 24 10 

clinical_engagement 
diagnosis 
demography 
58 new agents 
19 
disease_progression 
H-positive risk:  871 974 110 917 410 129 827 390 122 66 124 60 
H-negative risk:  974 871 827 917 390 410 129 110 124 122 60 66 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 26 11 

clinical_engagement 
diagnosis 
demography 
65 new agents 
20 
disease_progression 
H-positive risk:  872 989 109 922 406 130 821 382 121 64 123 61 
H-negative risk:  989 872 821 922 382 406 130 109 123 121 61 64 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 26 12 

clinical_engagement 
diagnosis 
demography 
56 new agents 
21 
disease_progression 
H-positive risk:  881 988 109 921 403 130 822 378 122 64 125 57 
H-negative risk:  988 881 822 921 378 403 130 109 125 122 57 64 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 27 12 

clinical_engagement 
diagnosis 
demography 
70 new agents 
22 
disease_progression 
H-positive risk:  884 988 109 926 393 133 827 374 120 65 126 55 
H-negative risk:  988 884 827 926 374 393 133 109 126 120 55 65 
New BC onsets:  44
BC status:  4956 44 
BC subtype:  4956 32 12 

clinical_engagement 
diagnosis 
demography 
67 new agents 
23 
disease_progression 
H-positive risk:  894 994 111 924 385 133 830 368 118 63 127 53 
H-negative risk:  994 894 830 924 368 385 133 111 127 118 53 63 
New BC onsets:  48
BC status:  4952 48 
BC subtype:  4952 36 12 

clinical_engagement 
diagnosis 
demography 
50 new agents 
24 
disease_progression 
H-positive risk:  898 998 113 919 381 135 828 367 116 64 129 52 
H-negative risk:  998 898 828 919 367 381 135 113 129 116 52 64 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 38 11 

clinical_engagement 
diagnosis 
demography 
57 new agents 
25 
disease_progression 
H-positive risk:  834 930 102 992 381 123 891 363 126 64 143 51 
H-negative risk:  930 834 891 992 363 381 123 102 143 126 51 64 
New BC onsets:  51
BC status:  4949 51 
BC subtype:  4949 40 11 

clinical_engagement 
diagnosis 
demography 
176 new agents 
26 
disease_progression 
H-positive risk:  857 941 103 957 384 126 865 386 126 64 137 54 
H-negative risk:  941 857 865 957 386 384 126 103 137 126 54 64 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 39 14 

clinical_engagement 
diagnosis 
demography 
73 new agents 
27 
disease_progression 
H-positive risk:  867 944 102 952 384 127 856 386 128 62 138 54 
H-negative risk:  944 867 856 952 386 384 127 102 138 128 54 62 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 43 14 

clinical_engagement 
diagnosis 
demography 
75 new agents 
28 
disease_progression 
H-positive risk:  875 947 104 949 383 125 852 381 129 64 136 55 
H-negative risk:  947 875 852 949 381 383 125 104 136 129 55 64 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 45 15 

clinical_engagement 
diagnosis 
demography 
55 new agents 
29 
disease_progression 
H-positive risk:  872 948 104 952 380 127 854 381 129 65 133 55 
H-negative risk:  948 872 854 952 381 380 127 104 133 129 55 65 
New BC onsets:  61
BC status:  4939 61 
BC subtype:  4939 45 16 

clinical_engagement 
diagnosis 
demography 
60 new agents 
30 
disease_progression 
H-positive risk:  882 943 104 960 375 125 862 371 127 65 131 55 
H-negative risk:  943 882 862 960 371 375 125 104 131 127 55 65 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 46 16 

clinical_engagement 
diagnosis 
demography 
56 new agents 
31 
disease_progression 
H-positive risk:  886 943 104 954 372 127 866 369 129 67 132 51 
H-negative risk:  943 886 866 954 369 372 127 104 132 129 51 67 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 49 16 

clinical_engagement 
diagnosis 
demography 
57 new agents 
32 
disease_progression 
H-positive risk:  891 942 105 961 372 126 858 369 131 65 130 50 
H-negative risk:  942 891 858 961 369 372 126 105 130 131 50 65 
New BC onsets:  62
BC status:  4938 62 
BC subtype:  4938 46 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
33 
disease_progression 
H-positive risk:  896 939 109 962 372 127 856 366 132 65 126 50 
H-negative risk:  939 896 856 962 366 372 127 109 126 132 50 65 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 49 16 

clinical_engagement 
diagnosis 
demography 
53 new agents 
34 
disease_progression 
H-positive risk:  894 939 109 957 374 128 858 368 132 65 127 49 
H-negative risk:  939 894 858 957 368 374 128 109 127 132 49 65 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 49 16 

clinical_engagement 
diagnosis 
demography 
58 new agents 
35 
disease_progression 
H-positive risk:  899 946 110 955 374 128 845 370 135 63 127 48 
H-negative risk:  946 899 845 955 370 374 128 110 127 135 48 63 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 50 17 

clinical_engagement 
diagnosis 
demography 
76 new agents 
36 
disease_progression 
H-positive risk:  901 950 112 948 379 128 850 363 132 63 126 48 
H-negative risk:  950 901 850 948 363 379 128 112 126 132 48 63 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 50 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
37 
disease_progression 
H-positive risk:  843 885 107 1015 375 124 908 365 135 62 132 49 
H-negative risk:  885 843 908 1015 365 375 124 107 132 135 49 62 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 53 18 

clinical_engagement 
diagnosis 
demography 
166 new agents 
38 
disease_progression 
H-positive risk:  843 915 107 970 403 129 879 374 134 62 129 55 
H-negative risk:  915 843 879 970 374 403 129 107 129 134 55 62 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 53 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
39 
disease_progression 
H-positive risk:  841 914 105 966 402 131 873 385 133 64 129 57 
H-negative risk:  914 841 873 966 385 402 131 105 129 133 57 64 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 55 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
40 
disease_progression 
H-positive risk:  845 920 105 971 393 134 867 383 132 64 129 57 
H-negative risk:  920 845 867 971 383 393 134 105 129 132 57 64 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 57 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
41 
disease_progression 
H-positive risk:  850 922 106 967 396 135 865 376 132 64 131 56 
H-negative risk:  922 850 865 967 376 396 135 106 131 132 56 64 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 56 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
42 
disease_progression 
H-positive risk:  853 927 108 969 398 135 857 369 134 64 131 55 
H-negative risk:  927 853 857 969 369 398 135 108 131 134 55 64 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 54 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
43 
disease_progression 
H-positive risk:  851 934 110 972 398 136 853 365 132 63 133 53 
H-negative risk:  934 851 853 972 365 398 136 110 133 132 53 63 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 56 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
44 
disease_progression 
H-positive risk:  857 930 109 971 401 135 845 368 130 65 136 53 
H-negative risk:  930 857 845 971 368 401 135 109 136 130 53 65 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 57 25 

clinical_engagement 
diagnosis 
demography 
60 new agents 
45 
disease_progression 
H-positive risk:  858 933 109 976 400 135 838 368 130 66 135 52 
H-negative risk:  933 858 838 976 368 400 135 109 135 130 52 66 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 60 25 

clinical_engagement 
diagnosis 
demography 
64 new agents 
46 
disease_progression 
H-positive risk:  870 933 110 975 391 136 842 359 131 65 135 53 
H-negative risk:  933 870 842 975 359 391 136 110 135 131 53 65 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 63 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
47 
disease_progression 
H-positive risk:  870 934 112 977 387 138 833 363 134 64 134 54 
H-negative risk:  934 870 833 977 363 387 138 112 134 134 54 64 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
55 new agents 
48 
disease_progression 
H-positive risk:  877 939 113 976 382 138 831 358 136 62 133 55 
H-negative risk:  939 877 831 976 358 382 138 113 133 136 55 62 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
60 new agents 
49 
disease_progression 
H-positive risk:  823 875 108 1041 382 130 888 360 142 62 133 56 
H-negative risk:  875 823 888 1041 360 382 130 108 133 142 56 62 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
156 new agents 
50 
disease_progression 
H-positive risk:  838 871 110 1023 398 132 868 374 136 65 132 53 
H-negative risk:  871 838 868 1023 374 398 132 110 132 136 53 65 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
51 
disease_progression 
H-positive risk:  848 878 112 1012 401 134 856 373 133 69 132 52 
H-negative risk:  878 848 856 1012 373 401 134 112 132 133 52 69 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
55 new agents 
52 
disease_progression 
H-positive risk:  849 882 114 1011 394 134 857 373 134 67 132 53 
H-negative risk:  882 849 857 1011 373 394 134 114 132 134 53 67 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 67 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
53 
disease_progression 
H-positive risk:  849 889 111 1008 391 135 861 366 137 67 132 54 
H-negative risk:  889 849 861 1008 366 391 135 111 132 137 54 67 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
54 
disease_progression 
H-positive risk:  844 892 112 1002 389 137 866 368 137 66 133 54 
H-negative risk:  892 844 866 1002 368 389 137 112 133 137 54 66 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
59 new agents 
55 
disease_progression 
H-positive risk:  850 896 112 999 382 136 871 364 137 65 132 56 
H-negative risk:  896 850 871 999 364 382 136 112 132 137 56 65 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 62 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
56 
disease_progression 
H-positive risk:  850 891 114 995 386 136 874 367 139 63 131 54 
H-negative risk:  891 850 874 995 367 386 136 114 131 139 54 63 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 64 25 

clinical_engagement 
diagnosis 
demography 
56 new agents 
57 
disease_progression 
H-positive risk:  843 892 115 998 386 135 877 366 137 65 132 54 
H-negative risk:  892 843 877 998 366 386 135 115 132 137 54 65 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
58 
disease_progression 
H-positive risk:  849 900 115 993 384 134 874 364 135 67 131 54 
H-negative risk:  900 849 874 993 364 384 134 115 131 135 54 67 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
62 new agents 
59 
disease_progression 
H-positive risk:  850 901 115 991 387 131 873 367 133 66 131 55 
H-negative risk:  901 850 873 991 367 387 131 115 131 133 55 66 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
60 
disease_progression 
H-positive risk:  854 907 116 981 383 129 878 363 133 69 132 55 
H-negative risk:  907 854 878 981 363 383 129 116 132 133 55 69 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
54 new agents 
61 
disease_progression 
H-positive risk:  812 862 111 1020 383 117 925 367 144 68 135 56 
H-negative risk:  862 812 925 1020 367 383 117 111 135 144 56 68 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
109 new agents 
62 
disease_progression 
H-positive risk:  816 861 112 977 410 115 921 385 147 66 132 58 
H-negative risk:  861 816 921 977 385 410 115 112 132 147 58 66 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 75 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
63 
disease_progression 
H-positive risk:  817 875 112 967 404 118 927 379 144 66 134 57 
H-negative risk:  875 817 927 967 379 404 118 112 134 144 57 66 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
64 
disease_progression 
H-positive risk:  822 872 115 959 406 119 934 374 143 67 135 54 
H-negative risk:  872 822 934 959 374 406 119 115 135 143 54 67 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 79 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
65 
disease_progression 
H-positive risk:  819 875 115 956 408 117 940 375 144 63 136 52 
H-negative risk:  875 819 940 956 375 408 117 115 136 144 52 63 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
66 
disease_progression 
H-positive risk:  819 878 117 959 400 117 942 373 145 65 134 51 
H-negative risk:  878 819 942 959 373 400 117 117 134 145 51 65 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
67 
disease_progression 
H-positive risk:  817 883 115 966 394 116 939 372 147 63 137 51 
H-negative risk:  883 817 939 966 372 394 116 115 137 147 51 63 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 69 23 

clinical_engagement 
diagnosis 
demography 
57 new agents 
68 
disease_progression 
H-positive risk:  818 880 115 958 397 117 946 372 145 62 137 53 
H-negative risk:  880 818 946 958 372 397 117 115 137 145 53 62 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
69 
disease_progression 
H-positive risk:  816 878 117 958 400 120 951 365 144 58 138 55 
H-negative risk:  878 816 951 958 365 400 120 117 138 144 55 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
55 new agents 
70 
disease_progression 
H-positive risk:  811 882 117 961 403 122 953 359 139 58 140 55 
H-negative risk:  882 811 953 961 359 403 122 117 140 139 55 58 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
71 
disease_progression 
H-positive risk:  815 886 119 964 404 120 956 351 138 56 139 52 
H-negative risk:  886 815 956 964 351 404 120 119 139 138 52 56 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
57 new agents 
72 
disease_progression 
H-positive risk:  811 886 120 963 400 117 972 351 137 53 138 52 
H-negative risk:  886 811 972 963 351 400 117 120 138 137 52 53 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
57 new agents 
73 
disease_progression 
H-positive risk:  754 815 111 1038 401 112 1029 346 142 54 147 51 
H-negative risk:  815 754 1029 1038 346 401 112 111 147 142 51 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
121 new agents 
74 
disease_progression 
H-positive risk:  765 815 115 1003 424 116 1020 350 140 51 147 54 
H-negative risk:  815 765 1020 1003 350 424 116 115 147 140 54 51 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 68 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
75 
disease_progression 
H-positive risk:  769 818 112 990 427 117 1017 360 133 53 150 54 
H-negative risk:  818 769 1017 990 360 427 117 112 150 133 54 53 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
76 
disease_progression 
H-positive risk:  773 818 113 992 426 114 1015 354 135 52 152 56 
H-negative risk:  818 773 1015 992 354 426 114 113 152 135 56 52 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
77 
disease_progression 
H-positive risk:  777 821 111 993 415 113 1016 354 137 53 153 57 
H-negative risk:  821 777 1016 993 354 415 113 111 153 137 57 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
78 
disease_progression 
H-positive risk:  774 824 112 995 416 113 1018 352 137 52 150 57 
H-negative risk:  824 774 1018 995 352 416 113 112 150 137 57 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
60 new agents 
79 
disease_progression 
H-positive risk:  777 826 110 1001 417 112 1011 348 136 53 152 57 
H-negative risk:  826 777 1011 1001 348 417 112 110 152 136 57 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
66 new agents 
80 
disease_progression 
H-positive risk:  779 830 109 996 418 115 1016 346 132 52 154 53 
H-negative risk:  830 779 1016 996 346 418 115 109 154 132 53 52 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 73 17 

clinical_engagement 
diagnosis 
demography 
65 new agents 
81 
disease_progression 
H-positive risk:  782 827 110 995 418 115 1016 349 133 53 151 51 
H-negative risk:  827 782 1016 995 349 418 115 110 151 133 51 53 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
91 new agents 
82 
disease_progression 
H-positive risk:  787 837 110 992 411 116 1020 339 136 54 146 52 
H-negative risk:  837 787 1020 992 339 411 116 110 146 136 52 54 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 72 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
83 
disease_progression 
H-positive risk:  788 833 110 1001 406 116 1020 337 138 51 150 50 
H-negative risk:  833 788 1020 1001 337 406 116 110 150 138 50 51 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 71 16 

clinical_engagement 
diagnosis 
demography 
82 new agents 
84 
disease_progression 
H-positive risk:  789 835 110 1005 404 115 1013 339 139 53 149 49 
H-negative risk:  835 789 1013 1005 339 404 115 110 149 139 49 53 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 70 17 

clinical_engagement 
diagnosis 
demography 
64 new agents 
85 
disease_progression 
H-positive risk:  738 770 100 1073 398 110 1070 342 145 50 158 46 
H-negative risk:  770 738 1070 1073 342 398 110 100 158 145 46 50 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 70 16 

clinical_engagement 
diagnosis 
demography 
94 new agents 
86 
disease_progression 
H-positive risk:  742 775 101 1053 410 110 1046 365 144 52 154 48 
H-negative risk:  775 742 1046 1053 365 410 110 101 154 144 48 52 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 70 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
87 
disease_progression 
H-positive risk:  741 771 100 1056 413 111 1047 369 139 53 152 48 
H-negative risk:  771 741 1047 1056 369 413 111 100 152 139 48 53 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
88 
disease_progression 
H-positive risk:  742 772 100 1056 412 114 1046 362 141 53 151 51 
H-negative risk:  772 742 1046 1056 362 412 114 100 151 141 51 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
89 
disease_progression 
H-positive risk:  759 769 96 1063 407 114 1039 364 138 52 149 50 
H-negative risk:  769 759 1039 1063 364 407 114 96 149 138 50 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
90 
disease_progression 
H-positive risk:  765 771 99 1058 403 113 1044 359 140 50 146 52 
H-negative risk:  771 765 1044 1058 359 403 113 99 146 140 52 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
91 
disease_progression 
H-positive risk:  761 770 103 1052 399 112 1045 364 141 53 145 55 
H-negative risk:  770 761 1045 1052 364 399 112 103 145 141 55 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
84 new agents 
92 
disease_progression 
H-positive risk:  766 772 105 1044 393 113 1051 364 138 53 145 56 
H-negative risk:  772 766 1051 1044 364 393 113 105 145 138 56 53 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
93 
disease_progression 
H-positive risk:  760 776 103 1049 398 111 1044 360 139 56 147 57 
H-negative risk:  776 760 1044 1049 360 398 111 103 147 139 57 56 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
94 
disease_progression 
H-positive risk:  764 781 106 1047 396 110 1045 355 139 54 145 58 
H-negative risk:  781 764 1045 1047 355 396 110 106 145 139 58 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
58 new agents 
95 
disease_progression 
H-positive risk:  774 775 106 1048 404 110 1041 346 138 55 143 60 
H-negative risk:  775 774 1041 1048 346 404 110 106 143 138 60 55 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 73 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
96 
disease_progression 
H-positive risk:  777 778 104 1057 399 110 1042 338 136 57 142 60 
H-negative risk:  778 777 1042 1057 338 399 110 104 142 136 60 57 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
97 
disease_progression 
H-positive risk:  742 744 97 1083 406 102 1084 340 141 55 148 58 
H-negative risk:  744 742 1084 1083 340 406 102 97 148 141 58 55 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
104 new agents 
98 
disease_progression 
H-positive risk:  739 741 95 1091 413 101 1062 356 147 52 148 55 
H-negative risk:  741 739 1062 1091 356 413 101 95 148 147 55 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
99 
disease_progression 
H-positive risk:  743 747 98 1087 409 100 1061 358 144 50 149 54 
H-negative risk:  747 743 1061 1087 358 409 100 98 149 144 54 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 76 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
100 
disease_progression 
H-positive risk:  746 745 96 1088 410 102 1062 355 144 46 149 57 
H-negative risk:  745 746 1062 1088 355 410 102 96 149 144 57 46 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
101 
disease_progression 
H-positive risk:  746 747 98 1087 409 104 1064 349 144 45 148 59 
H-negative risk:  747 746 1064 1087 349 409 104 98 148 144 59 45 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
102 
disease_progression 
H-positive risk:  745 748 96 1079 413 106 1067 351 142 45 150 58 
H-negative risk:  748 745 1067 1079 351 413 106 96 150 142 58 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
103 
disease_progression 
H-positive risk:  742 748 100 1079 412 105 1061 360 143 47 144 59 
H-negative risk:  748 742 1061 1079 360 412 105 100 144 143 59 47 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
104 
disease_progression 
H-positive risk:  742 747 100 1077 415 103 1062 361 145 44 147 57 
H-negative risk:  747 742 1062 1077 361 415 103 100 147 145 57 44 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 75 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
105 
disease_progression 
H-positive risk:  737 751 101 1081 408 104 1065 365 142 43 148 55 
H-negative risk:  751 737 1065 1081 365 408 104 101 148 142 55 43 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
106 
disease_progression 
H-positive risk:  740 747 101 1085 407 106 1060 362 143 45 149 55 
H-negative risk:  747 740 1060 1085 362 407 106 101 149 143 55 45 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
107 
disease_progression 
H-positive risk:  740 750 103 1077 405 107 1062 360 144 45 151 56 
H-negative risk:  750 740 1062 1077 360 405 107 103 151 144 56 45 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
108 
disease_progression 
H-positive risk:  739 746 105 1079 402 109 1065 362 141 47 149 56 
H-negative risk:  746 739 1065 1079 362 402 109 105 149 141 56 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
109 
disease_progression 
H-positive risk:  686 704 102 1125 399 100 1114 368 149 48 149 56 
H-negative risk:  704 686 1114 1125 368 399 100 102 149 149 56 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
98 new agents 
110 
disease_progression 
H-positive risk:  678 697 102 1134 394 102 1105 382 148 51 151 56 
H-negative risk:  697 678 1105 1134 382 394 102 102 151 148 56 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
93 new agents 
111 
disease_progression 
H-positive risk:  689 699 102 1135 393 104 1097 383 146 48 150 54 
H-negative risk:  699 689 1097 1135 383 393 104 102 150 146 54 48 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
112 
disease_progression 
H-positive risk:  683 707 103 1133 386 103 1098 386 147 51 148 55 
H-negative risk:  707 683 1098 1133 386 386 103 103 148 147 55 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 72 28 

clinical_engagement 
diagnosis 
demography 
77 new agents 
113 
disease_progression 
H-positive risk:  690 706 103 1132 382 102 1100 382 148 51 146 58 
H-negative risk:  706 690 1100 1132 382 382 102 103 146 148 58 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
114 
disease_progression 
H-positive risk:  687 706 98 1141 378 99 1105 383 148 50 147 58 
H-negative risk:  706 687 1105 1141 383 378 99 98 147 148 58 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
56 new agents 
115 
disease_progression 
H-positive risk:  688 714 96 1137 377 99 1106 379 148 51 147 58 
H-negative risk:  714 688 1106 1137 379 377 99 96 147 148 58 51 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
66 new agents 
116 
disease_progression 
H-positive risk:  684 708 98 1137 384 101 1101 385 146 52 145 59 
H-negative risk:  708 684 1101 1137 385 384 101 98 145 146 59 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 80 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
117 
disease_progression 
H-positive risk:  679 707 103 1135 391 101 1101 383 145 51 147 57 
H-negative risk:  707 679 1101 1135 383 391 101 103 147 145 57 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 82 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
118 
disease_progression 
H-positive risk:  684 706 103 1139 387 99 1110 379 142 50 144 57 
H-negative risk:  706 684 1110 1139 379 387 99 103 144 142 57 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 82 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
119 
disease_progression 
H-positive risk:  681 711 102 1142 380 100 1103 384 143 49 146 59 
H-negative risk:  711 681 1103 1142 384 380 100 102 146 143 59 49 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
120 
disease_progression 
H-positive risk:  690 713 103 1137 379 99 1096 383 145 46 148 61 
H-negative risk:  713 690 1096 1137 383 379 99 103 148 145 61 46 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
74 new agents 
121 
disease_progression 
H-positive risk:  653 661 98 1180 377 100 1140 387 151 44 148 61 
H-negative risk:  661 653 1140 1180 387 377 100 98 148 151 61 44 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
122 
disease_progression 
H-positive risk:  648 655 98 1168 384 97 1129 405 154 48 148 66 
H-negative risk:  655 648 1129 1168 405 384 97 98 148 154 66 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
123 
disease_progression 
H-positive risk:  647 659 98 1165 388 100 1132 405 151 48 143 64 
H-negative risk:  659 647 1132 1165 405 388 100 98 143 151 64 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
124 
disease_progression 
H-positive risk:  652 664 93 1165 386 100 1134 399 154 47 142 64 
H-negative risk:  664 652 1134 1165 399 386 100 93 142 154 64 47 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
90 new agents 
125 
disease_progression 
H-positive risk:  660 660 94 1160 379 101 1139 393 158 46 147 63 
H-negative risk:  660 660 1139 1160 393 379 101 94 147 158 63 46 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
74 new agents 
126 
disease_progression 
H-positive risk:  654 667 96 1150 379 102 1140 392 162 48 145 65 
H-negative risk:  667 654 1140 1150 392 379 102 96 145 162 65 48 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
127 
disease_progression 
H-positive risk:  657 670 97 1154 377 102 1140 388 161 47 145 62 
H-negative risk:  670 657 1140 1154 388 377 102 97 145 161 62 47 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
128 
disease_progression 
H-positive risk:  653 670 103 1153 380 101 1145 381 163 44 145 62 
H-negative risk:  670 653 1145 1153 381 380 101 103 145 163 62 44 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
129 
disease_progression 
H-positive risk:  656 677 103 1151 372 103 1141 377 166 45 145 64 
H-negative risk:  677 656 1141 1151 377 372 103 103 145 166 64 45 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
130 
disease_progression 
H-positive risk:  651 671 102 1154 371 101 1148 374 168 47 148 65 
H-negative risk:  671 651 1148 1154 374 371 101 102 148 168 65 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 76 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
131 
disease_progression 
H-positive risk:  655 676 100 1152 369 102 1146 368 168 51 151 62 
H-negative risk:  676 655 1146 1152 368 369 102 100 151 168 62 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
62 new agents 
132 
disease_progression 
H-positive risk:  655 676 101 1145 367 102 1149 373 167 52 150 63 
H-negative risk:  676 655 1149 1145 373 367 102 101 150 167 63 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
87 new agents 
133 
disease_progression 
H-positive risk:  658 678 102 1149 360 103 1145 368 166 54 153 64 
H-negative risk:  678 658 1145 1149 368 360 103 102 153 166 64 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 75 21 

clinical_engagement 
diagnosis 
demography 
93 new agents 
134 
disease_progression 
H-positive risk:  649 668 102 1144 369 104 1133 394 159 58 155 65 
H-negative risk:  668 649 1133 1144 394 369 104 102 155 159 65 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
135 
disease_progression 
H-positive risk:  640 668 105 1147 370 105 1141 391 157 57 155 64 
H-negative risk:  668 640 1141 1147 391 370 105 105 155 157 64 57 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
136 
disease_progression 
H-positive risk:  644 658 105 1144 364 109 1144 395 158 58 157 64 
H-negative risk:  658 644 1144 1144 395 364 109 105 157 158 64 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
137 
disease_progression 
H-positive risk:  637 652 106 1145 363 111 1147 402 158 59 160 60 
H-negative risk:  652 637 1147 1145 402 363 111 106 160 158 60 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
138 
disease_progression 
H-positive risk:  636 648 106 1145 368 109 1144 413 157 58 157 59 
H-negative risk:  648 636 1144 1145 413 368 109 106 157 157 59 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
139 
disease_progression 
H-positive risk:  632 645 108 1149 363 110 1146 415 156 60 157 59 
H-negative risk:  645 632 1146 1149 415 363 110 108 157 156 59 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
140 
disease_progression 
H-positive risk:  635 646 107 1158 359 109 1144 413 154 58 158 59 
H-negative risk:  646 635 1144 1158 413 359 109 107 158 154 59 58 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
141 
disease_progression 
H-positive risk:  637 645 106 1171 352 112 1134 408 156 60 162 57 
H-negative risk:  645 637 1134 1171 408 352 112 106 162 156 57 60 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 80 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
142 
disease_progression 
H-positive risk:  630 653 105 1171 346 114 1135 408 158 61 159 60 
H-negative risk:  653 630 1135 1171 408 346 114 105 159 158 60 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
143 
disease_progression 
H-positive risk:  628 654 105 1164 340 114 1138 416 161 61 158 61 
H-negative risk:  654 628 1138 1164 416 340 114 105 158 161 61 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
144 
disease_progression 
H-positive risk:  627 656 101 1162 344 115 1134 419 159 63 157 63 
H-negative risk:  656 627 1134 1162 419 344 115 101 157 159 63 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
145 
disease_progression 
H-positive risk:  632 656 100 1167 348 112 1129 422 160 60 154 60 
H-negative risk:  656 632 1129 1167 422 348 112 100 154 160 60 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
146 
disease_progression 
H-positive risk:  627 652 100 1157 371 112 1116 425 163 61 151 65 
H-negative risk:  652 627 1116 1157 425 371 112 100 151 163 65 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
147 
disease_progression 
H-positive risk:  636 650 100 1160 366 112 1100 436 162 59 154 65 
H-negative risk:  650 636 1100 1160 436 366 112 100 154 162 65 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
148 
disease_progression 
H-positive risk:  641 653 102 1161 359 112 1087 435 169 61 153 67 
H-negative risk:  653 641 1087 1161 435 359 112 102 153 169 67 61 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
149 
disease_progression 
H-positive risk:  639 655 101 1154 362 112 1087 436 172 61 153 68 
H-negative risk:  655 639 1087 1154 436 362 112 101 153 172 68 61 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
150 
disease_progression 
H-positive risk:  642 654 101 1159 354 111 1083 440 174 58 156 68 
H-negative risk:  654 642 1083 1159 440 354 111 101 156 174 68 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
61 new agents 
151 
disease_progression 
H-positive risk:  637 655 100 1158 362 109 1084 436 176 56 156 71 
H-negative risk:  655 637 1084 1158 436 362 109 100 156 176 71 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
152 
disease_progression 
H-positive risk:  639 654 101 1162 364 107 1081 438 174 54 158 68 
H-negative risk:  654 639 1081 1162 438 364 107 101 158 174 68 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
90 new agents 
153 
disease_progression 
H-positive risk:  639 665 101 1157 369 105 1082 429 177 53 157 66 
H-negative risk:  665 639 1082 1157 429 369 105 101 157 177 66 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
154 
disease_progression 
H-positive risk:  638 666 102 1163 366 104 1082 428 170 54 162 65 
H-negative risk:  666 638 1082 1163 428 366 104 102 162 170 65 54 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
155 
disease_progression 
H-positive risk:  633 669 104 1157 363 104 1090 427 173 50 165 65 
H-negative risk:  669 633 1090 1157 427 363 104 104 165 173 65 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
156 
disease_progression 
H-positive risk:  634 664 103 1159 361 106 1095 426 172 49 168 63 
H-negative risk:  664 634 1095 1159 426 361 106 103 168 172 63 49 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
157 
disease_progression 
H-positive risk:  634 668 103 1156 364 105 1099 419 174 50 167 61 
H-negative risk:  668 634 1099 1156 419 364 105 103 167 174 61 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
96 new agents 
158 
disease_progression 
H-positive risk:  631 677 103 1155 374 106 1083 417 174 50 167 63 
H-negative risk:  677 631 1083 1155 417 374 106 103 167 174 63 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
159 
disease_progression 
H-positive risk:  634 678 105 1159 373 104 1083 408 170 52 168 66 
H-negative risk:  678 634 1083 1159 408 373 104 105 168 170 66 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
160 
disease_progression 
H-positive risk:  630 682 105 1150 374 104 1089 410 171 52 168 65 
H-negative risk:  682 630 1089 1150 410 374 104 105 168 171 65 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
161 
disease_progression 
H-positive risk:  632 681 105 1153 369 105 1090 408 171 52 166 68 
H-negative risk:  681 632 1090 1153 408 369 105 105 166 171 68 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 72 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
162 
disease_progression 
H-positive risk:  630 684 104 1148 371 104 1090 408 174 51 169 67 
H-negative risk:  684 630 1090 1148 408 371 104 104 169 174 67 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
163 
disease_progression 
H-positive risk:  626 685 104 1150 369 103 1096 406 174 53 169 65 
H-negative risk:  685 626 1096 1150 406 369 103 104 169 174 65 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 72 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
164 
disease_progression 
H-positive risk:  631 692 101 1148 369 102 1100 396 172 53 172 64 
H-negative risk:  692 631 1100 1148 396 369 102 101 172 172 64 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 73 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
165 
disease_progression 
H-positive risk:  628 694 102 1143 368 100 1096 406 177 49 171 66 
H-negative risk:  694 628 1096 1143 406 368 100 102 171 177 66 49 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
166 
disease_progression 
H-positive risk:  626 688 103 1145 367 97 1092 414 181 51 170 66 
H-negative risk:  688 626 1092 1145 414 367 97 103 170 181 66 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 71 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
167 
disease_progression 
H-positive risk:  630 687 99 1141 371 97 1095 408 180 52 170 70 
H-negative risk:  687 630 1095 1141 408 371 97 99 170 180 70 52 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
168 
disease_progression 
H-positive risk:  629 697 99 1138 372 96 1089 407 181 52 170 70 
H-negative risk:  697 629 1089 1138 407 372 96 99 170 181 70 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
169 
disease_progression 
H-positive risk:  629 701 100 1134 375 97 1083 403 184 55 169 70 
H-negative risk:  701 629 1083 1134 403 375 97 100 169 184 70 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
103 new agents 
170 
disease_progression 
H-positive risk:  637 693 99 1139 381 97 1081 393 180 55 168 77 
H-negative risk:  693 637 1081 1139 393 381 97 99 168 180 77 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
171 
disease_progression 
H-positive risk:  635 693 99 1136 387 94 1087 393 181 55 166 74 
H-negative risk:  693 635 1087 1136 393 387 94 99 166 181 74 55 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 67 22 

clinical_engagement 
diagnosis 
demography 
56 new agents 
172 
disease_progression 
H-positive risk:  640 689 100 1134 391 91 1083 397 182 55 162 76 
H-negative risk:  689 640 1083 1134 397 391 91 100 162 182 76 55 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 68 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
173 
disease_progression 
H-positive risk:  643 685 99 1130 391 92 1087 403 185 50 163 72 
H-negative risk:  685 643 1087 1130 403 391 92 99 163 185 72 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
84 new agents 
174 
disease_progression 
H-positive risk:  642 693 97 1127 387 92 1088 405 183 50 163 73 
H-negative risk:  693 642 1088 1127 405 387 92 97 163 183 73 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 72 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
175 
disease_progression 
H-positive risk:  650 695 96 1126 387 89 1078 410 186 48 163 72 
H-negative risk:  695 650 1078 1126 410 387 89 96 163 186 72 48 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
176 
disease_progression 
H-positive risk:  653 698 98 1122 388 87 1079 411 187 49 160 68 
H-negative risk:  698 653 1079 1122 411 388 87 98 160 187 68 49 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 73 19 

clinical_engagement 
diagnosis 
demography 
87 new agents 
177 
disease_progression 
H-positive risk:  658 690 97 1117 388 86 1078 413 193 51 161 68 
H-negative risk:  690 658 1078 1117 413 388 86 97 161 193 68 51 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
178 
disease_progression 
H-positive risk:  655 686 102 1121 386 86 1078 414 193 50 158 71 
H-negative risk:  686 655 1078 1121 414 386 86 102 158 193 71 50 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 71 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
179 
disease_progression 
H-positive risk:  651 686 103 1121 393 86 1073 416 193 50 157 71 
H-negative risk:  686 651 1073 1121 416 393 86 103 157 193 71 50 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 71 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
180 
disease_progression 
H-positive risk:  648 690 102 1122 398 86 1072 408 193 51 159 71 
H-negative risk:  690 648 1072 1122 408 398 86 102 159 193 71 51 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 69 18 

clinical_engagement 
diagnosis 
demography 
75 new agents 
181 
disease_progression 
H-positive risk:  652 684 106 1118 399 86 1074 405 194 51 159 72 
H-negative risk:  684 652 1074 1118 405 399 86 106 159 194 72 51 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 71 14 

clinical_engagement 
diagnosis 
demography 
98 new agents 
182 
disease_progression 
H-positive risk:  648 683 108 1118 405 88 1075 407 189 50 158 71 
H-negative risk:  683 648 1075 1118 407 405 88 108 158 189 71 50 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 68 14 

clinical_engagement 
diagnosis 
demography 
67 new agents 
183 
disease_progression 
H-positive risk:  641 678 110 1112 408 85 1088 412 188 49 155 74 
H-negative risk:  678 641 1088 1112 412 408 85 110 155 188 74 49 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 67 14 

clinical_engagement 
diagnosis 
demography 
85 new agents 
184 
disease_progression 
H-positive risk:  659 678 109 1116 399 84 1077 413 190 48 154 73 
H-negative risk:  678 659 1077 1116 413 399 84 109 154 190 73 48 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 67 15 

clinical_engagement 
diagnosis 
demography 
71 new agents 
185 
disease_progression 
H-positive risk:  648 681 110 1118 402 83 1084 410 189 48 157 70 
H-negative risk:  681 648 1084 1118 410 402 83 110 157 189 70 48 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
186 
disease_progression 
H-positive risk:  650 678 112 1116 411 84 1081 408 187 52 154 67 
H-negative risk:  678 650 1081 1116 408 411 84 112 154 187 67 52 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 71 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
187 
disease_progression 
H-positive risk:  653 679 111 1115 412 83 1082 404 186 53 156 66 
H-negative risk:  679 653 1082 1115 404 412 83 111 156 186 66 53 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 73 14 

clinical_engagement 
diagnosis 
demography 
79 new agents 
188 
disease_progression 
H-positive risk:  653 676 113 1108 408 84 1087 411 183 52 158 67 
H-negative risk:  676 653 1087 1108 411 408 84 113 158 183 67 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
69 new agents 
189 
disease_progression 
H-positive risk:  647 680 114 1104 412 85 1092 409 184 51 156 66 
H-negative risk:  680 647 1092 1104 409 412 85 114 156 184 66 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
190 
disease_progression 
H-positive risk:  658 680 110 1094 414 88 1094 407 180 51 159 65 
H-negative risk:  680 658 1094 1094 407 414 88 110 159 180 65 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 81 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
191 
disease_progression 
H-positive risk:  665 672 111 1095 413 87 1089 414 181 50 156 67 
H-negative risk:  672 665 1089 1095 414 413 87 111 156 181 67 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
80 new agents 
192 
disease_progression 
H-positive risk:  672 665 109 1103 411 89 1089 408 178 53 157 66 
H-negative risk:  665 672 1089 1103 408 411 89 109 157 178 66 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 86 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
193 
disease_progression 
H-positive risk:  674 661 108 1111 416 92 1078 410 177 53 153 67 
H-negative risk:  661 674 1078 1111 410 416 92 108 153 177 67 53 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
87 new agents 
194 
disease_progression 
H-positive risk:  673 668 106 1102 421 96 1068 416 177 51 153 69 
H-negative risk:  668 673 1068 1102 416 421 96 106 153 177 69 51 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
92 new agents 
195 
disease_progression 
H-positive risk:  672 669 109 1102 414 97 1066 420 173 53 158 67 
H-negative risk:  669 672 1066 1102 420 414 97 109 158 173 67 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
196 
disease_progression 
H-positive risk:  667 668 109 1094 416 96 1070 422 176 54 161 67 
H-negative risk:  668 667 1070 1094 422 416 96 109 161 176 67 54 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
197 
disease_progression 
H-positive risk:  666 671 108 1089 416 95 1078 419 176 57 160 65 
H-negative risk:  671 666 1078 1089 419 416 95 108 160 176 65 57 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
198 
disease_progression 
H-positive risk:  663 674 107 1092 423 94 1075 418 172 57 161 64 
H-negative risk:  674 663 1075 1092 418 423 94 107 161 172 64 57 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
199 
disease_progression 
H-positive risk:  675 681 106 1081 416 97 1075 416 171 57 162 63 
H-negative risk:  681 675 1075 1081 416 416 97 106 162 171 63 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
200 
disease_progression 
H-positive risk:  678 692 104 1080 412 97 1073 415 166 59 161 63 
H-negative risk:  692 678 1073 1080 415 412 97 104 161 166 63 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
201 
disease_progression 
H-positive risk:  681 690 104 1084 408 95 1071 415 168 60 160 64 
H-negative risk:  690 681 1071 1084 415 408 95 104 160 168 64 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
202 
disease_progression 
H-positive risk:  684 684 102 1093 404 97 1070 412 167 58 165 64 
H-negative risk:  684 684 1070 1093 412 404 97 102 165 167 64 58 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
203 
disease_progression 
H-positive risk:  684 673 102 1089 413 99 1074 409 167 57 169 64 
H-negative risk:  673 684 1074 1089 409 413 99 102 169 167 64 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
204 
disease_progression 
H-positive risk:  677 678 101 1090 412 99 1074 408 164 62 170 65 
H-negative risk:  678 677 1074 1090 408 412 99 101 170 164 65 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
80 new agents 
205 
disease_progression 
H-positive risk:  669 681 100 1100 403 100 1080 408 162 63 167 67 
H-negative risk:  681 669 1080 1100 408 403 100 100 167 162 67 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 90 20 

clinical_engagement 
diagnosis 
demography 
86 new agents 
206 
disease_progression 
H-positive risk:  668 672 102 1105 404 99 1083 410 160 65 164 68 
H-negative risk:  672 668 1083 1105 410 404 99 102 164 160 68 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
207 
disease_progression 
H-positive risk:  661 673 100 1106 403 101 1089 413 158 66 162 68 
H-negative risk:  673 661 1089 1106 413 403 101 100 162 158 68 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
208 
disease_progression 
H-positive risk:  665 672 99 1100 417 104 1079 414 158 62 163 67 
H-negative risk:  672 665 1079 1100 414 417 104 99 163 158 67 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
209 
disease_progression 
H-positive risk:  663 679 98 1102 415 99 1078 411 162 60 168 65 
H-negative risk:  679 663 1078 1102 411 415 99 98 168 162 65 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
210 
disease_progression 
H-positive risk:  670 684 95 1095 423 98 1071 407 161 63 168 65 
H-negative risk:  684 670 1071 1095 407 423 98 95 168 161 65 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
211 
disease_progression 
H-positive risk:  672 687 93 1090 423 100 1072 404 157 66 171 65 
H-negative risk:  687 672 1072 1090 404 423 100 93 171 157 65 66 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
70 new agents 
212 
disease_progression 
H-positive risk:  673 681 94 1092 421 99 1074 409 155 63 174 65 
H-negative risk:  681 673 1074 1092 409 421 99 94 174 155 65 63 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
213 
disease_progression 
H-positive risk:  674 689 96 1087 419 97 1065 416 156 63 172 66 
H-negative risk:  689 674 1065 1087 416 419 97 96 172 156 66 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
214 
disease_progression 
H-positive risk:  681 686 98 1088 416 96 1063 417 155 63 171 66 
H-negative risk:  686 681 1063 1088 417 416 96 98 171 155 66 63 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 90 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
215 
disease_progression 
H-positive risk:  684 691 102 1092 403 94 1066 419 154 61 169 65 
H-negative risk:  691 684 1066 1092 419 403 94 102 169 154 65 61 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
66 new agents 
216 
disease_progression 
H-positive risk:  698 681 102 1099 402 94 1063 414 151 62 168 66 
H-negative risk:  681 698 1063 1099 414 402 94 102 168 151 66 62 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
78 new agents 
217 
disease_progression 
H-positive risk:  691 687 99 1091 416 95 1061 414 150 66 159 71 
H-negative risk:  687 691 1061 1091 414 416 95 99 159 150 71 66 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
89 new agents 
218 
disease_progression 
H-positive risk:  695 701 99 1088 413 96 1053 406 152 67 160 70 
H-negative risk:  701 695 1053 1088 406 413 96 99 160 152 70 67 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 89 27 

clinical_engagement 
diagnosis 
demography 
75 new agents 
219 
disease_progression 
H-positive risk:  695 697 97 1080 423 95 1060 407 149 66 162 69 
H-negative risk:  697 695 1060 1080 407 423 95 97 162 149 69 66 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
55 new agents 
220 
disease_progression 
H-positive risk:  688 704 99 1081 425 92 1049 418 150 66 159 69 
H-negative risk:  704 688 1049 1081 418 425 92 99 159 150 69 66 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
221 
disease_progression 
H-positive risk:  686 702 98 1087 423 90 1055 417 151 66 161 64 
H-negative risk:  702 686 1055 1087 417 423 90 98 161 151 64 66 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
222 
disease_progression 
H-positive risk:  692 699 101 1087 424 90 1052 416 151 64 160 64 
H-negative risk:  699 692 1052 1087 416 424 90 101 160 151 64 64 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
223 
disease_progression 
H-positive risk:  691 705 104 1095 418 93 1051 412 150 59 159 63 
H-negative risk:  705 691 1051 1095 412 418 93 104 159 150 63 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
69 new agents 
224 
disease_progression 
H-positive risk:  693 702 100 1087 419 95 1052 419 149 62 161 61 
H-negative risk:  702 693 1052 1087 419 419 95 100 161 149 61 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
225 
disease_progression 
H-positive risk:  699 701 100 1086 418 96 1047 416 147 62 164 64 
H-negative risk:  701 699 1047 1086 416 418 96 100 164 147 64 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
226 
disease_progression 
H-positive risk:  701 698 100 1091 417 99 1041 417 145 62 164 65 
H-negative risk:  698 701 1041 1091 417 417 99 100 164 145 65 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
227 
disease_progression 
H-positive risk:  699 701 99 1100 407 99 1042 417 144 64 164 64 
H-negative risk:  701 699 1042 1100 417 407 99 99 164 144 64 64 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
81 new agents 
228 
disease_progression 
H-positive risk:  694 703 97 1102 406 98 1052 413 145 62 165 63 
H-negative risk:  703 694 1052 1102 413 406 98 97 165 145 63 62 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
229 
disease_progression 
H-positive risk:  696 702 96 1096 410 99 1038 428 140 65 165 65 
H-negative risk:  702 696 1038 1096 428 410 99 96 165 140 65 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
230 
disease_progression 
H-positive risk:  694 711 95 1102 402 97 1040 420 144 64 166 65 
H-negative risk:  711 694 1040 1102 420 402 97 95 166 144 65 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
231 
disease_progression 
H-positive risk:  695 716 97 1094 403 98 1039 419 136 71 167 65 
H-negative risk:  716 695 1039 1094 419 403 98 97 167 136 65 71 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
90 new agents 
232 
disease_progression 
H-positive risk:  700 714 101 1092 403 95 1041 417 137 70 164 66 
H-negative risk:  714 700 1041 1092 417 403 95 101 164 137 66 70 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
233 
disease_progression 
H-positive risk:  697 712 104 1102 402 96 1040 417 136 71 161 62 
H-negative risk:  712 697 1040 1102 417 402 96 104 161 136 62 71 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
61 new agents 
234 
disease_progression 
H-positive risk:  696 706 105 1112 392 97 1040 423 136 68 164 61 
H-negative risk:  706 696 1040 1112 423 392 97 105 164 136 61 68 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
235 
disease_progression 
H-positive risk:  700 707 106 1102 398 92 1048 418 142 66 162 59 
H-negative risk:  707 700 1048 1102 418 398 92 106 162 142 59 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
236 
disease_progression 
H-positive risk:  703 699 106 1101 398 93 1054 422 141 66 161 56 
H-negative risk:  699 703 1054 1101 422 398 93 106 161 141 56 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
237 
disease_progression 
H-positive risk:  705 698 104 1112 397 92 1048 414 142 67 166 55 
H-negative risk:  698 705 1048 1112 414 397 92 104 166 142 55 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
238 
disease_progression 
H-positive risk:  704 701 102 1116 398 91 1044 409 142 67 171 55 
H-negative risk:  701 704 1044 1116 409 398 91 102 171 142 55 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
239 
disease_progression 
H-positive risk:  705 700 101 1120 400 94 1044 409 140 65 169 53 
H-negative risk:  700 705 1044 1120 409 400 94 101 169 140 53 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
240 
disease_progression 
H-positive risk:  704 702 102 1115 397 93 1055 406 143 64 166 53 
H-negative risk:  702 704 1055 1115 406 397 93 102 166 143 53 64 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
241 
disease_progression 
H-positive risk:  713 697 99 1107 407 94 1043 412 142 66 165 55 
H-negative risk:  697 713 1043 1107 412 407 94 99 165 142 55 66 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
242 
disease_progression 
H-positive risk:  712 693 95 1107 414 95 1045 409 141 66 171 52 
H-negative risk:  693 712 1045 1107 409 414 95 95 171 141 52 66 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
87 new agents 
243 
disease_progression 
H-positive risk:  710 689 99 1106 408 96 1046 412 145 67 170 52 
H-negative risk:  689 710 1046 1106 412 408 96 99 170 145 52 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
244 
disease_progression 
H-positive risk:  701 687 101 1107 414 91 1049 411 150 66 171 52 
H-negative risk:  687 701 1049 1107 411 414 91 101 171 150 52 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
245 
disease_progression 
H-positive risk:  699 691 99 1105 413 89 1054 411 149 67 172 51 
H-negative risk:  691 699 1054 1105 411 413 89 99 172 149 51 67 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
246 
disease_progression 
H-positive risk:  699 693 104 1098 420 89 1045 421 146 65 171 49 
H-negative risk:  693 699 1045 1098 421 420 89 104 171 146 49 65 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
247 
disease_progression 
H-positive risk:  694 694 109 1102 418 88 1047 425 145 62 164 52 
H-negative risk:  694 694 1047 1102 425 418 88 109 164 145 52 62 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
248 
disease_progression 
H-positive risk:  687 700 107 1097 422 85 1053 424 148 61 166 50 
H-negative risk:  700 687 1053 1097 424 422 85 107 166 148 50 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
249 
disease_progression 
H-positive risk:  679 704 107 1102 421 86 1061 414 148 61 167 50 
H-negative risk:  704 679 1061 1102 414 421 86 107 167 148 50 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
250 
disease_progression 
H-positive risk:  677 700 104 1104 425 83 1060 422 147 61 168 49 
H-negative risk:  700 677 1060 1104 422 425 83 104 168 147 49 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 83 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
251 
disease_progression 
H-positive risk:  679 705 105 1101 418 84 1066 416 147 62 169 48 
H-negative risk:  705 679 1066 1101 416 418 84 105 169 147 48 62 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
252 
disease_progression 
H-positive risk:  683 700 104 1092 420 85 1082 410 148 60 167 49 
H-negative risk:  700 683 1082 1092 410 420 85 104 167 148 49 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 84 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
253 
disease_progression 
H-positive risk:  680 710 103 1082 425 85 1085 406 147 63 165 49 
H-negative risk:  710 680 1085 1082 406 425 85 103 165 147 49 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
254 
disease_progression 
H-positive risk:  682 714 103 1068 432 82 1089 407 146 66 165 46 
H-negative risk:  714 682 1089 1068 407 432 82 103 165 146 46 66 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
255 
disease_progression 
H-positive risk:  687 711 100 1060 437 80 1098 402 148 66 164 47 
H-negative risk:  711 687 1098 1060 402 437 80 100 164 148 47 66 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
256 
disease_progression 
H-positive risk:  681 707 102 1060 435 80 1110 399 148 67 165 46 
H-negative risk:  707 681 1110 1060 399 435 80 102 165 148 46 67 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
257 
disease_progression 
H-positive risk:  678 702 106 1058 434 82 1117 394 150 67 162 50 
H-negative risk:  702 678 1117 1058 394 434 82 106 162 150 50 67 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 87 19 

clinical_engagement 
diagnosis 
demography 
75 new agents 
258 
disease_progression 
H-positive risk:  672 707 101 1071 432 82 1119 384 150 66 165 51 
H-negative risk:  707 672 1119 1071 384 432 82 101 165 150 51 66 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
259 
disease_progression 
H-positive risk:  679 706 100 1073 429 83 1119 379 150 65 167 50 
H-negative risk:  706 679 1119 1073 379 429 83 100 167 150 50 65 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 88 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
260 
disease_progression 
H-positive risk:  674 712 99 1069 431 83 1122 381 148 64 165 52 
H-negative risk:  712 674 1122 1069 381 431 83 99 165 148 52 64 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 85 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
261 
disease_progression 
H-positive risk:  670 712 101 1071 427 82 1124 382 152 63 165 51 
H-negative risk:  712 670 1124 1071 382 427 82 101 165 152 51 63 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
83 new agents 
262 
disease_progression 
H-positive risk:  666 715 100 1068 429 82 1122 381 155 64 164 54 
H-negative risk:  715 666 1122 1068 381 429 82 100 164 155 54 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 88 16 

clinical_engagement 
diagnosis 
demography 
83 new agents 
263 
disease_progression 
H-positive risk:  667 722 102 1064 432 83 1109 385 156 62 163 55 
H-negative risk:  722 667 1109 1064 385 432 83 102 163 156 55 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 87 16 

clinical_engagement 
diagnosis 
demography 
90 new agents 
264 
disease_progression 
H-positive risk:  668 726 104 1067 422 84 1112 383 156 60 162 56 
H-negative risk:  726 668 1112 1067 383 422 84 104 162 156 56 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 84 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
265 
disease_progression 
H-positive risk:  660 729 107 1054 418 84 1125 390 155 58 161 59 
H-negative risk:  729 660 1125 1054 390 418 84 107 161 155 59 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 81 17 

clinical_engagement 
diagnosis 
demography 
68 new agents 
266 
disease_progression 
H-positive risk:  658 721 109 1056 421 83 1120 401 154 60 158 59 
H-negative risk:  721 658 1120 1056 401 421 83 109 158 154 59 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
267 
disease_progression 
H-positive risk:  656 729 108 1055 427 83 1116 398 153 58 158 59 
H-negative risk:  729 656 1116 1055 398 427 83 108 158 153 59 58 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
268 
disease_progression 
H-positive risk:  647 724 110 1062 428 86 1116 397 150 59 161 60 
H-negative risk:  724 647 1116 1062 397 428 86 110 161 150 60 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 88 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
269 
disease_progression 
H-positive risk:  652 721 108 1070 421 89 1115 392 151 56 164 61 
H-negative risk:  721 652 1115 1070 392 421 89 108 164 151 61 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 93 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
270 
disease_progression 
H-positive risk:  654 730 105 1060 424 86 1119 388 152 59 163 60 
H-negative risk:  730 654 1119 1060 388 424 86 105 163 152 60 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
271 
disease_progression 
H-positive risk:  659 727 107 1061 420 87 1122 383 152 55 168 59 
H-negative risk:  727 659 1122 1061 383 420 87 107 168 152 59 55 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
76 new agents 
272 
disease_progression 
H-positive risk:  660 728 108 1067 418 85 1110 388 154 55 168 59 
H-negative risk:  728 660 1110 1067 388 418 85 108 168 154 59 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
64 new agents 
273 
disease_progression 
H-positive risk:  653 727 107 1066 420 84 1116 389 155 55 165 63 
H-negative risk:  727 653 1116 1066 389 420 84 107 165 155 63 55 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
274 
disease_progression 
H-positive risk:  650 723 111 1061 420 83 1120 394 155 55 167 61 
H-negative risk:  723 650 1120 1061 394 420 83 111 167 155 61 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
275 
disease_progression 
H-positive risk:  649 724 112 1054 423 81 1124 398 154 56 166 59 
H-negative risk:  724 649 1124 1054 398 423 81 112 166 154 59 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
276 
disease_progression 
H-positive risk:  642 722 112 1058 423 84 1121 406 152 54 166 60 
H-negative risk:  722 642 1121 1058 406 423 84 112 166 152 60 54 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
277 
disease_progression 
H-positive risk:  644 732 113 1055 419 81 1121 403 153 55 165 59 
H-negative risk:  732 644 1121 1055 403 419 81 113 165 153 59 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 85 19 

clinical_engagement 
diagnosis 
demography 
83 new agents 
278 
disease_progression 
H-positive risk:  651 728 113 1058 417 81 1121 403 149 56 164 59 
H-negative risk:  728 651 1121 1058 403 417 81 113 164 149 59 56 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
279 
disease_progression 
H-positive risk:  657 728 113 1058 420 80 1105 411 151 54 163 60 
H-negative risk:  728 657 1105 1058 411 420 80 113 163 151 60 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
280 
disease_progression 
H-positive risk:  658 735 112 1054 420 78 1099 415 146 58 165 60 
H-negative risk:  735 658 1099 1054 415 420 78 112 165 146 60 58 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
281 
disease_progression 
H-positive risk:  657 742 112 1059 414 76 1097 413 146 57 169 58 
H-negative risk:  742 657 1097 1059 413 414 76 112 169 146 58 57 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
282 
disease_progression 
H-positive risk:  662 741 111 1052 420 77 1095 421 142 56 167 56 
H-negative risk:  741 662 1095 1052 421 420 77 111 167 142 56 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
283 
disease_progression 
H-positive risk:  662 740 113 1051 414 80 1092 421 143 55 173 56 
H-negative risk:  740 662 1092 1051 421 414 80 113 173 143 56 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
284 
disease_progression 
H-positive risk:  662 735 115 1050 418 82 1089 425 144 53 172 55 
H-negative risk:  735 662 1089 1050 425 418 82 115 172 144 55 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
285 
disease_progression 
H-positive risk:  661 733 112 1062 415 82 1086 427 143 53 172 54 
H-negative risk:  733 661 1086 1062 427 415 82 112 172 143 54 53 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
62 new agents 
286 
disease_progression 
H-positive risk:  656 727 111 1063 425 84 1085 429 140 55 169 56 
H-negative risk:  727 656 1085 1063 429 425 84 111 169 140 56 55 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
287 
disease_progression 
H-positive risk:  662 724 110 1063 423 83 1083 427 140 57 172 56 
H-negative risk:  724 662 1083 1063 427 423 83 110 172 140 56 57 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
288 
disease_progression 
H-positive risk:  661 724 113 1066 423 84 1078 429 134 58 171 59 
H-negative risk:  724 661 1078 1066 429 423 84 113 171 134 59 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 91 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
289 
disease_progression 
H-positive risk:  657 733 114 1064 415 86 1084 428 133 59 169 58 
H-negative risk:  733 657 1084 1064 428 415 86 114 169 133 58 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
290 
disease_progression 
H-positive risk:  656 735 113 1068 417 83 1078 431 134 60 171 54 
H-negative risk:  735 656 1078 1068 431 417 83 113 171 134 54 60 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
291 
disease_progression 
H-positive risk:  656 729 114 1076 413 83 1080 432 135 59 170 53 
H-negative risk:  729 656 1080 1076 432 413 83 114 170 135 53 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 87 25 

clinical_engagement 
diagnosis 
demography 
84 new agents 
292 
disease_progression 
H-positive risk:  655 735 116 1071 411 83 1088 426 134 62 168 51 
H-negative risk:  735 655 1088 1071 426 411 83 116 168 134 51 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 86 25 

clinical_engagement 
diagnosis 
demography 
89 new agents 
293 
disease_progression 
H-positive risk:  660 727 116 1073 411 80 1093 422 136 61 170 51 
H-negative risk:  727 660 1093 1073 422 411 80 116 170 136 51 61 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
294 
disease_progression 
H-positive risk:  660 728 120 1074 416 80 1082 421 138 60 170 51 
H-negative risk:  728 660 1082 1074 421 416 80 120 170 138 51 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
295 
disease_progression 
H-positive risk:  660 725 120 1079 416 80 1076 418 141 60 173 52 
H-negative risk:  725 660 1076 1079 418 416 80 120 173 141 52 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 93 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
296 
disease_progression 
H-positive risk:  656 728 120 1078 419 80 1077 412 142 61 177 50 
H-negative risk:  728 656 1077 1078 412 419 80 120 177 142 50 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
98 new agents 
297 
disease_progression 
H-positive risk:  658 718 124 1094 408 82 1084 402 138 63 177 52 
H-negative risk:  718 658 1084 1094 402 408 82 124 177 138 52 63 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 92 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
298 
disease_progression 
H-positive risk:  668 720 123 1085 411 85 1087 394 137 63 174 53 
H-negative risk:  720 668 1087 1085 394 411 85 123 174 137 53 63 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
299 
disease_progression 
H-positive risk:  685 713 124 1088 405 86 1082 394 136 63 175 49 
H-negative risk:  713 685 1082 1088 394 405 86 124 175 136 49 63 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 92 27 

clinical_engagement 
diagnosis 
demography 
88 new agents 
300 
disease_progression 
H-positive risk:  689 717 122 1081 406 83 1077 402 136 65 174 48 
H-negative risk:  717 689 1077 1081 402 406 83 122 174 136 48 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 87 31 

clinical_engagement 
diagnosis 
demography 
62 new agents 
301 
disease_progression 
H-positive risk:  688 713 121 1087 413 82 1066 409 134 65 171 51 
H-negative risk:  713 688 1066 1087 409 413 82 121 171 134 51 65 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 86 30 

clinical_engagement 
diagnosis 
demography 
85 new agents 
302 
disease_progression 
H-positive risk:  689 710 118 1082 409 86 1072 412 134 65 171 52 
H-negative risk:  710 689 1072 1082 412 409 86 118 171 134 52 65 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 82 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
303 
disease_progression 
H-positive risk:  682 711 116 1084 405 87 1071 417 133 62 178 54 
H-negative risk:  711 682 1071 1084 417 405 87 116 178 133 54 62 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 85 30 

clinical_engagement 
diagnosis 
demography 
55 new agents 
304 
disease_progression 
H-positive risk:  683 705 119 1091 401 86 1065 423 133 61 179 54 
H-negative risk:  705 683 1065 1091 423 401 86 119 179 133 54 61 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
305 
disease_progression 
H-positive risk:  691 708 124 1092 398 84 1054 430 130 62 175 52 
H-negative risk:  708 691 1054 1092 430 398 84 124 175 130 52 62 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 85 31 

clinical_engagement 
diagnosis 
demography 
72 new agents 
306 
disease_progression 
H-positive risk:  689 706 122 1094 401 84 1048 428 133 63 180 52 
H-negative risk:  706 689 1048 1094 428 401 84 122 180 133 52 63 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 87 32 

clinical_engagement 
diagnosis 
demography 
68 new agents 
307 
disease_progression 
H-positive risk:  684 704 119 1088 409 81 1049 432 134 65 182 53 
H-negative risk:  704 684 1049 1088 432 409 81 119 182 134 53 65 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 86 34 

clinical_engagement 
diagnosis 
demography 
76 new agents 
308 
disease_progression 
H-positive risk:  688 706 122 1093 403 82 1045 429 136 64 180 52 
H-negative risk:  706 688 1045 1093 429 403 82 122 180 136 52 64 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 81 34 

clinical_engagement 
diagnosis 
demography 
73 new agents 
309 
disease_progression 
H-positive risk:  692 706 121 1090 410 82 1039 433 136 62 178 51 
H-negative risk:  706 692 1039 1090 433 410 82 121 178 136 51 62 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 83 34 

clinical_engagement 
diagnosis 
demography 
73 new agents 
310 
disease_progression 
H-positive risk:  695 711 122 1081 407 81 1040 439 138 61 174 51 
H-negative risk:  711 695 1040 1081 439 407 81 122 174 138 51 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 83 34 

clinical_engagement 
diagnosis 
demography 
83 new agents 
311 
disease_progression 
H-positive risk:  689 712 122 1087 393 82 1045 446 136 61 172 55 
H-negative risk:  712 689 1045 1087 446 393 82 122 172 136 55 61 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 84 32 

clinical_engagement 
diagnosis 
demography 
48 new agents 
312 
disease_progression 
H-positive risk:  688 709 118 1090 397 83 1044 445 136 61 174 55 
H-negative risk:  709 688 1044 1090 445 397 83 118 174 136 55 61 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 86 32 

clinical_engagement 
diagnosis 
demography 
88 new agents 
313 
disease_progression 
H-positive risk:  694 708 116 1102 391 82 1035 440 139 61 178 54 
H-negative risk:  708 694 1035 1102 440 391 82 116 178 139 54 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 85 32 

clinical_engagement 
diagnosis 
demography 
78 new agents 
314 
disease_progression 
H-positive risk:  681 712 119 1103 391 80 1042 447 139 58 172 56 
H-negative risk:  712 681 1042 1103 447 391 80 119 172 139 56 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 83 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
315 
disease_progression 
H-positive risk:  679 706 122 1106 389 81 1042 447 140 60 171 57 
H-negative risk:  706 679 1042 1106 447 389 81 122 171 140 57 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 81 30 

clinical_engagement 
diagnosis 
demography 
89 new agents 
316 
disease_progression 
H-positive risk:  687 714 120 1103 381 81 1038 448 137 62 173 56 
H-negative risk:  714 687 1038 1103 448 381 81 120 173 137 56 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 80 30 

clinical_engagement 
diagnosis 
demography 
72 new agents 
317 
disease_progression 
H-positive risk:  688 716 122 1098 385 82 1031 446 141 59 174 58 
H-negative risk:  716 688 1031 1098 446 385 82 122 174 141 58 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 80 35 

clinical_engagement 
diagnosis 
demography 
66 new agents 
318 
disease_progression 
H-positive risk:  687 711 122 1101 388 79 1030 446 141 61 175 59 
H-negative risk:  711 687 1030 1101 446 388 79 122 175 141 59 61 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 80 36 

clinical_engagement 
diagnosis 
demography 
76 new agents 
319 
disease_progression 
H-positive risk:  692 706 118 1093 397 84 1038 436 139 61 174 62 
H-negative risk:  706 692 1038 1093 436 397 84 118 174 139 62 61 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 81 35 

clinical_engagement 
diagnosis 
demography 
86 new agents 
320 
disease_progression 
H-positive risk:  689 708 121 1098 390 84 1039 433 138 62 177 61 
H-negative risk:  708 689 1039 1098 433 390 84 121 177 138 61 62 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 82 37 

clinical_engagement 
diagnosis 
demography 
76 new agents 
321 
disease_progression 
H-positive risk:  695 707 122 1091 394 84 1039 433 137 64 173 61 
H-negative risk:  707 695 1039 1091 433 394 84 122 173 137 61 64 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 82 38 

clinical_engagement 
diagnosis 
demography 
71 new agents 
322 
disease_progression 
H-positive risk:  697 704 122 1097 393 84 1036 431 140 61 172 63 
H-negative risk:  704 697 1036 1097 431 393 84 122 172 140 63 61 
New BC onsets:  122
BC status:  4878 122 
BC subtype:  4878 83 39 

clinical_engagement 
diagnosis 
demography 
86 new agents 
323 
disease_progression 
H-positive risk:  690 698 125 1093 405 85 1040 434 139 61 166 64 
H-negative risk:  698 690 1040 1093 434 405 85 125 166 139 64 61 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 83 37 

clinical_engagement 
diagnosis 
demography 
68 new agents 
324 
disease_progression 
H-positive risk:  689 693 123 1095 398 84 1048 440 142 57 168 63 
H-negative risk:  693 689 1048 1095 440 398 84 123 168 142 63 57 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 82 37 

clinical_engagement 
diagnosis 
demography 
63 new agents 
325 
disease_progression 
H-positive risk:  679 684 119 1100 394 85 1057 444 144 58 172 64 
H-negative risk:  684 679 1057 1100 444 394 85 119 172 144 64 58 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 85 38 

clinical_engagement 
diagnosis 
demography 
72 new agents 
326 
disease_progression 
H-positive risk:  690 677 116 1100 394 85 1058 441 140 59 176 64 
H-negative risk:  677 690 1058 1100 441 394 85 116 176 140 64 59 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 83 38 

clinical_engagement 
diagnosis 
demography 
79 new agents 
327 
disease_progression 
H-positive risk:  690 675 115 1086 403 82 1067 439 142 59 177 65 
H-negative risk:  675 690 1067 1086 439 403 82 115 177 142 65 59 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 81 37 

clinical_engagement 
diagnosis 
demography 
75 new agents 
328 
disease_progression 
H-positive risk:  692 673 115 1086 397 82 1073 437 138 62 179 66 
H-negative risk:  673 692 1073 1086 437 397 82 115 179 138 66 62 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 81 37 

clinical_engagement 
diagnosis 
demography 
84 new agents 
329 
disease_progression 
H-positive risk:  694 673 114 1097 391 77 1074 437 140 62 175 66 
H-negative risk:  673 694 1074 1097 437 391 77 114 175 140 66 62 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 81 38 

clinical_engagement 
diagnosis 
demography 
78 new agents 
330 
disease_progression 
H-positive risk:  703 672 114 1090 389 79 1062 449 141 61 173 67 
H-negative risk:  672 703 1062 1090 449 389 79 114 173 141 67 61 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 86 39 

clinical_engagement 
diagnosis 
demography 
75 new agents 
331 
disease_progression 
H-positive risk:  692 674 114 1086 397 81 1065 454 139 58 170 70 
H-negative risk:  674 692 1065 1086 454 397 81 114 170 139 70 58 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 85 39 

clinical_engagement 
diagnosis 
demography 
69 new agents 
332 
disease_progression 
H-positive risk:  688 673 114 1087 398 79 1065 461 140 57 169 69 
H-negative risk:  673 688 1065 1087 461 398 79 114 169 140 69 57 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 84 43 

clinical_engagement 
diagnosis 
demography 
71 new agents 
333 
disease_progression 
H-positive risk:  684 671 113 1099 386 76 1072 464 144 55 167 69 
H-negative risk:  671 684 1072 1099 464 386 76 113 167 144 69 55 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 82 42 

clinical_engagement 
diagnosis 
demography 
73 new agents 
334 
disease_progression 
H-positive risk:  680 663 114 1105 390 78 1075 459 143 56 169 68 
H-negative risk:  663 680 1075 1105 459 390 78 114 169 143 68 56 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 83 42 

clinical_engagement 
diagnosis 
demography 
79 new agents 
335 
disease_progression 
H-positive risk:  681 661 117 1109 388 77 1080 452 142 57 169 67 
H-negative risk:  661 681 1080 1109 452 388 77 117 169 142 67 57 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 82 42 

clinical_engagement 
diagnosis 
demography 
80 new agents 
336 
disease_progression 
H-positive risk:  683 662 118 1110 382 79 1085 450 144 54 170 63 
H-negative risk:  662 683 1085 1110 450 382 79 118 170 144 63 54 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 83 42 

clinical_engagement 
diagnosis 
demography 
66 new agents 
337 
disease_progression 
H-positive risk:  688 659 119 1109 387 79 1084 446 144 53 170 62 
H-negative risk:  659 688 1084 1109 446 387 79 119 170 144 62 53 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 82 41 

clinical_engagement 
diagnosis 
demography 
74 new agents 
338 
disease_progression 
H-positive risk:  691 654 121 1112 383 79 1086 446 145 52 170 61 
H-negative risk:  654 691 1086 1112 446 383 79 121 170 145 61 52 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 84 41 

clinical_engagement 
diagnosis 
demography 
73 new agents 
339 
disease_progression 
H-positive risk:  699 662 119 1110 386 77 1080 445 144 52 169 57 
H-negative risk:  662 699 1080 1110 445 386 77 119 169 144 57 52 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 85 40 

clinical_engagement 
diagnosis 
demography 
87 new agents 
340 
disease_progression 
H-positive risk:  697 671 119 1105 386 77 1081 437 145 53 172 57 
H-negative risk:  671 697 1081 1105 437 386 77 119 172 145 57 53 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 85 42 

clinical_engagement 
diagnosis 
demography 
67 new agents 
341 
disease_progression 
H-positive risk:  700 670 122 1109 385 76 1070 443 146 49 173 57 
H-negative risk:  670 700 1070 1109 443 385 76 122 173 146 57 49 
New BC onsets:  129
BC status:  4871 129 
BC subtype:  4871 85 44 

clinical_engagement 
diagnosis 
demography 
88 new agents 
342 
disease_progression 
H-positive risk:  705 675 122 1102 393 78 1057 440 146 51 174 57 
H-negative risk:  675 705 1057 1102 440 393 78 122 174 146 57 51 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 83 43 

clinical_engagement 
diagnosis 
demography 
69 new agents 
343 
disease_progression 
H-positive risk:  703 683 120 1100 397 77 1061 439 142 50 171 57 
H-negative risk:  683 703 1061 1100 439 397 77 120 171 142 57 50 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 85 42 

clinical_engagement 
diagnosis 
demography 
71 new agents 
344 
disease_progression 
H-positive risk:  708 687 115 1098 402 77 1050 438 142 49 175 59 
H-negative risk:  687 708 1050 1098 438 402 77 115 175 142 59 49 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 83 43 

clinical_engagement 
diagnosis 
demography 
69 new agents 
345 
disease_progression 
H-positive risk:  711 692 113 1094 405 79 1047 439 141 49 172 58 
H-negative risk:  692 711 1047 1094 439 405 79 113 172 141 58 49 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 81 42 

clinical_engagement 
diagnosis 
demography 
84 new agents 
346 
disease_progression 
H-positive risk:  708 694 112 1088 403 81 1050 442 141 54 172 55 
H-negative risk:  694 708 1050 1088 442 403 81 112 172 141 55 54 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 78 41 

clinical_engagement 
diagnosis 
demography 
83 new agents 
347 
disease_progression 
H-positive risk:  706 695 113 1101 399 82 1048 436 137 57 169 57 
H-negative risk:  695 706 1048 1101 436 399 82 113 169 137 57 57 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 77 41 

clinical_engagement 
diagnosis 
demography 
85 new agents 
348 
disease_progression 
H-positive risk:  709 701 114 1102 395 83 1047 436 135 55 166 57 
H-negative risk:  701 709 1047 1102 436 395 83 114 166 135 57 55 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 78 43 

clinical_engagement 
diagnosis 
demography 
74 new agents 
349 
disease_progression 
H-positive risk:  714 697 115 1104 397 84 1039 439 137 54 165 55 
H-negative risk:  697 714 1039 1104 439 397 84 115 165 137 55 54 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 76 43 

clinical_engagement 
diagnosis 
demography 
81 new agents 
350 
disease_progression 
H-positive risk:  714 701 110 1093 400 87 1051 427 137 53 170 57 
H-negative risk:  701 714 1051 1093 427 400 87 110 170 137 57 53 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 76 43 

clinical_engagement 
diagnosis 
demography 
78 new agents 
351 
disease_progression 
H-positive risk:  709 694 108 1103 398 87 1061 423 136 56 170 55 
H-negative risk:  694 709 1061 1103 423 398 87 108 170 136 55 56 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 77 42 

clinical_engagement 
diagnosis 
demography 
72 new agents 
352 
disease_progression 
H-positive risk:  700 696 107 1109 395 86 1074 412 137 57 172 55 
H-negative risk:  696 700 1074 1109 412 395 86 107 172 137 55 57 
New BC onsets:  125
BC status:  4875 125 
BC subtype:  4875 84 41 

clinical_engagement 
diagnosis 
demography 
81 new agents 
353 
disease_progression 
H-positive risk:  691 690 107 1104 405 86 1082 407 140 58 173 57 
H-negative risk:  690 691 1082 1104 407 405 86 107 173 140 57 58 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 86 40 

clinical_engagement 
diagnosis 
demography 
62 new agents 
354 
disease_progression 
H-positive risk:  703 682 104 1107 411 85 1072 405 142 57 176 56 
H-negative risk:  682 703 1072 1107 405 411 85 104 176 142 56 57 
New BC onsets:  124
BC status:  4876 124 
BC subtype:  4876 84 40 

clinical_engagement 
diagnosis 
demography 
80 new agents 
355 
disease_progression 
H-positive risk:  701 680 103 1103 411 86 1086 401 139 62 175 53 
H-negative risk:  680 701 1086 1103 401 411 86 103 175 139 53 62 
New BC onsets:  123
BC status:  4877 123 
BC subtype:  4877 83 40 

clinical_engagement 
diagnosis 
demography 
83 new agents 
356 
disease_progression 
H-positive risk:  700 688 104 1105 411 84 1084 400 138 62 174 50 
H-negative risk:  688 700 1084 1105 400 411 84 104 174 138 50 62 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 87 40 

clinical_engagement 
diagnosis 
demography 
80 new agents 
357 
disease_progression 
H-positive risk:  701 677 104 1113 408 85 1089 396 138 61 175 53 
H-negative risk:  677 701 1089 1113 396 408 85 104 175 138 53 61 
New BC onsets:  127
BC status:  4873 127 
BC subtype:  4873 88 39 

clinical_engagement 
diagnosis 
demography 
62 new agents 
358 
disease_progression 
H-positive risk:  706 675 103 1102 413 89 1091 395 138 62 174 52 
H-negative risk:  675 706 1091 1102 395 413 89 103 174 138 52 62 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 89 39 

clinical_engagement 
diagnosis 
demography 
90 new agents 
359 
disease_progression 
H-positive risk:  699 679 100 1108 416 90 1100 387 137 59 174 51 
H-negative risk:  679 699 1100 1108 387 416 90 100 174 137 51 59 
New BC onsets:  126
BC status:  4874 126 
BC subtype:  4874 88 38 

clinical_engagement 
diagnosis 
demography 
75 new agents 
360 
disease_progression 
H-positive risk:  700 684 97 1106 420 90 1093 387 136 59 177 51 
H-negative risk:  684 700 1093 1106 387 420 90 97 177 136 51 59 
New BC onsets:  128
BC status:  4872 128 
BC subtype:  4872 90 38 

clinical_engagement 
diagnosis 
demography 
70 new agents 
Time difference of 16.73925 mins
This is task 23
date
